Innocare Optoelectronics: To announce the acquisition of a real estate right of use from a related party.


1.Name and nature of the underlying asset (e.g., land located at
Sublot XX, Lot XX, North District, Taichung City):Part of Right-of-use
asset-Buildings located in Room B, No.2,Sec. 2, Huansi Rd.,Tainan City,
Southern Taiwan Science Park,Taiwan (R.O.C.)
2.Date of the occurrence of the event:2022/04/12 ~ 2022/04/12
3.Transaction unit amount (e.g.XX square meters, equivalent
to XX ping), unit price, and total transaction price:
Transaction amount:
Transaction volume: The total area of the leased factory is 7,722.77
square meters
Unit Price: TWD 150 for 1 square meter monthly
Total transaction amount: Right-of-use asset-Buildings NT$39,475,976
4.Trading counterparty and its relationship to the
Company (if the trading counterparty is a natural
person and furthermore is not a related party of the
Company, the name of the trading counterparty is
not required to be disclosed):INX. Parent company.
5.Where the trading counterparty is a related party,
announcement shall also be made of the reason for
choosing the related party as trading counterparty and
the identity of the previous owner, its relationship with
the Company and the trading counterparty, and the
previous date and monetary value of transfer:
Reason for choosing the related party as trading counterpart:To consider
Group's operation strategy.
Identity of the previous owner (including its relationship with the company
and the trading counterpart), price of transfer and the date of
6.Where an owner of the underlying assets within the past
five years has been a related party of the Company, the
announcement shall also include the date and price of
acquisition and disposal by the related party, and its
relationship to the Company at the time of the
7.Projected gain (or loss) through disposal (not
applicable for acquisition of assets; those with deferral
should provide a table explaining recognition):N/A
8.Terms of delivery or payment (including payment period
and monetary value), restrictive covenants in the contract,
and other important terms and conditions:According to agreement; None; None
9.The manner of deciding on this transaction (such as
invitation to tender, price comparison, or price
negotiation), the reference basis for the decision
on price, and the decision-making department:
Negotiation; per market price; the Board of Directors.
10.Name of the professional appraisal firm or company
and its appraisal price:N/A
11.Name of the professional appraiser:N/A
12.Practice certificate number of the professional appraiser:N/A
13.The appraisal report has a limited price, specific price,
or special price:N/A
14.An appraisal report has not yet been obtained:N/A
15.Reason for an appraisal report not being obtained:N/A
16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:N/A
17.Name of the CPA firm:N/A
18.Name of the CPA:N/A
19.Practice certificate number of the CPA:N/A
20.Broker and broker's fee:N/A
21.Concrete purpose or use of the acquisition or disposal:
For production and operation purpose.
22.Any dissenting opinions of directors to the present transaction:None.
23.Whether the counterparty of the current transaction is a related party:Yes.
24.Date of the board of directors' resolution:2022/04/12
25.Date of ratification by supervisors or approval
by the audit committee:2022/04/12
26.The transaction is to acquire a real property or
right-of-use asset from a related party:Yes.
27.The price assessed in accordance with the Article 16
of the Regulations Governing the Acquisition and
Disposal of Assets by Public Companies:N/A
28.Where the above assessed price is lower than the
transaction price, the price assessed in accordance
with the Article 17 of the same regulations:N/A
29.Any other matters that need to be specified:None.